Objective: To explore the impact, reactions and coping methods of the significant others (SOs) of people with Ménière's disease (MD).

Design: SOs of people with MD were asked to answer open-ended questions reporting the 'life effects' and 'positive experiences' they have had as a result of the partner's condition. The replies to the 'life effects' question was categorized using the WHO-ICF framework. The responses of 'life effects' from this study and the 'positive experiences' reported in a recent study ( Manchaiah et al, 2013 ) were evaluated with K-means clustering analysis.

Study Sample: Eighty-eight SOs (42 male, 42 female, and four did not state gender).

Results: While the SOs mainly listed their own problems, a significant number of responses related to the problems of their partner. Personal perspectives tended to focus on the consequences of their partner's condition, whereas in perspectives of their partner they focussed on his/her symptoms. Further, replies from 81 SOs were used in evaluation of responses and were classified into four categories: constrained life attitude; disease burden attitude; care and support attitude; and social isolation attitude.

Conclusions: The results of this study support the importance of including the SO of people with MD in the rehabilitation process.

Download full-text PDF

Source
http://dx.doi.org/10.3109/14992027.2014.989547DOI Listing

Publication Analysis

Top Keywords

'life effects'
12
people ménière's
8
ménière's disease
8
sos people
8
'positive experiences'
8
partner's condition
8
sos
5
attitudes people
4
disease vary
4
vary coping
4

Similar Publications

Limited research has examined the effect of meal composition on sleep. Based on previous research, we hypothesized that a low glycemic index (LGI) drink containing 50 g isomaltulose (Palatinose, GI = 32) would result in more N3 sleep, less rapid eye movement (REM) sleep, and better memory consolidation than a high glycemic index (HGI) drink containing 50 g glucose (GI = 100). Healthy males (n = 20) attended the laboratory on three occasions at least a week apart (one acclimatization night and two test nights).

View Article and Find Full Text PDF

Rationale: Bilateral gluteus medius contractures in adults are rare in clinical practice, with only a few cases reported. These contractures may result from repeated intramuscular injections during childhood. Understanding the clinical manifestations, diagnostic process, treatment, and outcomes can provide insights into effective management strategies.

View Article and Find Full Text PDF

Background: In patients with advanced hepatocellular carcinoma (HCC) following sorafenib failure, regorafenib has been used as an initial second-line drug. It is unclear the real efficacy and safety of sorafenib-regorafenib sequential therapy compared to placebo or other treatment (cabozantinib or nivolumab or placebo) in advanced HCC.

Methods: Four electronic databases (PubMed, Embase, Web of Science, and Ovid) were systematically searched for eligible articles from their inception to July, 2024.

View Article and Find Full Text PDF

Objective: Epilepsy is a common neurological disease affecting nearly 1% of the global population, and temporal lobe epilepsy (TLE) is the most common type. Patients experience recurrent seizures and chronic cognitive deficits that can impact their quality of life, ability to work, and independence. These cognitive deficits often extend beyond the temporal lobe and are not well understood.

View Article and Find Full Text PDF

Background: Sarcopenia is closely associated with a poor quality of life and mortality, and its prevention and treatment represent a critical area of research. Resistance training is an effective treatment for older adults with sarcopenia. However, they often face challenges when receiving traditional rehabilitation treatments at hospitals.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!